A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study

A rapid, simple and sensitive ultra-high performance liquid chromatography–tandem mass spectrometric (UPLC–MS/MS) method was developed and validated for the determination of hederasaponin B, an active triterpenoid saponin widely existed in Hedera helix L. Plasma samples were processed by protein pre...

Full description

Bibliographic Details
Main Authors: Jiaxin Liu, Xueyan Yang, Lin Li, Qili Zhang, Zhaoyan Zhang, Xin Zhang, Yunli Zhao, Miao Yu, Zhiguo Yu
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087616300873
_version_ 1819294987752308736
author Jiaxin Liu
Xueyan Yang
Lin Li
Qili Zhang
Zhaoyan Zhang
Xin Zhang
Yunli Zhao
Miao Yu
Zhiguo Yu
author_facet Jiaxin Liu
Xueyan Yang
Lin Li
Qili Zhang
Zhaoyan Zhang
Xin Zhang
Yunli Zhao
Miao Yu
Zhiguo Yu
author_sort Jiaxin Liu
collection DOAJ
description A rapid, simple and sensitive ultra-high performance liquid chromatography–tandem mass spectrometric (UPLC–MS/MS) method was developed and validated for the determination of hederasaponin B, an active triterpenoid saponin widely existed in Hedera helix L. Plasma samples were processed by protein precipitation with acetonitrile and separated on a Thermo Hypersil GOLD C18 (2.1 mm × 50 mm,1.9 µm) at flow rate of 0.3 ml/min, with a gradient elution consisting of acetonitrile and water containing 0.1% (v/v) formic acid at 30 °C and detected by electrospray ionization mass spectrometry in the positive multiple reaction monitoring (MRM) mode. The linearity was found to be within the concentration range of 0.5–5000 ng/ml with a lower limit of quantification of 0.5 ng/ml. The absolute oral bioavailability of hederasaponin B was 0.24 ± 0.49%. This indicated that the concentration-time course of the hederasaponin B existed a double-peak phenomenon. This method was further applied to the determination of hederasaponin B in rat plasma and showed good practicability, for the first time, after intragastric (25 mg/kg) and intravenous (2 mg/kg) administration in rats.
first_indexed 2024-12-24T04:35:03Z
format Article
id doaj.art-8af15840fb84455380555d2e5ce2212d
institution Directory Open Access Journal
issn 1818-0876
language English
last_indexed 2024-12-24T04:35:03Z
publishDate 2017-07-01
publisher Elsevier
record_format Article
series Asian Journal of Pharmaceutical Sciences
spelling doaj.art-8af15840fb84455380555d2e5ce2212d2022-12-21T17:15:14ZengElsevierAsian Journal of Pharmaceutical Sciences1818-08762017-07-0112436336910.1016/j.ajps.2016.09.001A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic studyJiaxin LiuXueyan YangLin LiQili ZhangZhaoyan ZhangXin ZhangYunli ZhaoMiao YuZhiguo YuA rapid, simple and sensitive ultra-high performance liquid chromatography–tandem mass spectrometric (UPLC–MS/MS) method was developed and validated for the determination of hederasaponin B, an active triterpenoid saponin widely existed in Hedera helix L. Plasma samples were processed by protein precipitation with acetonitrile and separated on a Thermo Hypersil GOLD C18 (2.1 mm × 50 mm,1.9 µm) at flow rate of 0.3 ml/min, with a gradient elution consisting of acetonitrile and water containing 0.1% (v/v) formic acid at 30 °C and detected by electrospray ionization mass spectrometry in the positive multiple reaction monitoring (MRM) mode. The linearity was found to be within the concentration range of 0.5–5000 ng/ml with a lower limit of quantification of 0.5 ng/ml. The absolute oral bioavailability of hederasaponin B was 0.24 ± 0.49%. This indicated that the concentration-time course of the hederasaponin B existed a double-peak phenomenon. This method was further applied to the determination of hederasaponin B in rat plasma and showed good practicability, for the first time, after intragastric (25 mg/kg) and intravenous (2 mg/kg) administration in rats.http://www.sciencedirect.com/science/article/pii/S1818087616300873Hederasaponin BUPLC–MS/MSPharmacokineticsRat plasmaDouble-peak phenomenon
spellingShingle Jiaxin Liu
Xueyan Yang
Lin Li
Qili Zhang
Zhaoyan Zhang
Xin Zhang
Yunli Zhao
Miao Yu
Zhiguo Yu
A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
Asian Journal of Pharmaceutical Sciences
Hederasaponin B
UPLC–MS/MS
Pharmacokinetics
Rat plasma
Double-peak phenomenon
title A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
title_full A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
title_fullStr A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
title_full_unstemmed A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
title_short A rapid and sensitive liquid chromatography–tandem mass spectrometric method for the determination of hederasaponin B in rat plasma: Application to a pharmacokinetic study
title_sort rapid and sensitive liquid chromatography tandem mass spectrometric method for the determination of hederasaponin b in rat plasma application to a pharmacokinetic study
topic Hederasaponin B
UPLC–MS/MS
Pharmacokinetics
Rat plasma
Double-peak phenomenon
url http://www.sciencedirect.com/science/article/pii/S1818087616300873
work_keys_str_mv AT jiaxinliu arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT xueyanyang arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT linli arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT qilizhang arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT zhaoyanzhang arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT xinzhang arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT yunlizhao arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT miaoyu arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT zhiguoyu arapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT jiaxinliu rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT xueyanyang rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT linli rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT qilizhang rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT zhaoyanzhang rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT xinzhang rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT yunlizhao rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT miaoyu rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy
AT zhiguoyu rapidandsensitiveliquidchromatographytandemmassspectrometricmethodforthedeterminationofhederasaponinbinratplasmaapplicationtoapharmacokineticstudy